Abstract:Objectives:
Serological biomarkers, common to many areas of medicine, have the potential to inform on the health of the human body and to give early warning of risk of compromised function or illness before symptoms are experienced. Serological measurement of prestin, a motor protein uniquely produced and expressed in outer hair cells, has recently been identified as a potential biomarker to inform on the health of the cochlea. Before any test can be introduced into the clinical toolkit, the reprod… Show more
“…Previous reports suggested that EHF audiometry is generally better than standard audiometry and OAEs at detecting the early stages, i.e., small levels, of OHC loss 31 , 36 . Moreover, although we previously found a weak correlation between serum prestin levels and TEOAEs 15 , unlike serum prestin, TEOAEs did not correlate with noise exposure levels in the current study. Thus, either noise-related OHC damage is too small to be detected by audiometry and TEOAEs but can be detected by serum prestin levels, or low serum prestin levels in the At-Risk group is being driven by a factor other than OHC loss, as we consider next.…”
Section: Discussioncontrasting
confidence: 99%
“…That is, prestin may be removed from the inner ear as part of the normal proteomic recycling (turnover) processes that maintain cellular homeostasis. Consistent with this proposed homeostatic mechanism, we have previously shown that the healthy ear has stable levels of prestin molecules in circulation 15 . Possible mechanisms for uptake, recycling, and sorting of plasma-membrane proteins, such as prestin in the OHCs.…”
Section: Introductionsupporting
confidence: 66%
“…The results of our previous studies led us to hypothesize that lower levels of serum prestin could follow cochlear injury and be the result of fewer in-tact OHCs undergoing normal prestin production and turnover 15 , 17 , 18 . In our animal model studies, significant noise-induced loss of OHCs was confirmed histologically and manifested as noise induced changes in distortion product OAE levels and auditory brainstem response thresholds 17 , 18 .…”
Section: Discussionmentioning
confidence: 99%
“…We have previously used animal models to demonstrate changes to serum prestin after a traumatic noise event that resulted in hearing loss from OHC death 17 , 18 . A parallel literature is also emerging in humans 15 , 19 , 20 . For example, in our recent work in young adults with clinically normal audiograms (the current clinical gold standard for diagnosing sensorineural hearing loss from noise or other sources), we demonstrated that serum prestin levels have high test–retest reliability, using an experimental approach where serum was obtained at five time points over the span of multiple months 15 .…”
Section: Introductionmentioning
confidence: 96%
“…A parallel literature is also emerging in humans 15 , 19 , 20 . For example, in our recent work in young adults with clinically normal audiograms (the current clinical gold standard for diagnosing sensorineural hearing loss from noise or other sources), we demonstrated that serum prestin levels have high test–retest reliability, using an experimental approach where serum was obtained at five time points over the span of multiple months 15 . We found that while serum prestin levels were stable over this time window on the individual level, there was considerable between-subject variation, despite all participants having clinically normal audiometric function.…”
Serological biomarkers of inner ear proteins are a promising new approach for studying human hearing. Here, we focus on the serological measurement of prestin, a protein integral to a human’s highly sensitive hearing, expressed in cochlear outer hair cells (OHCs). Building from recent nonhuman studies that associated noise-induced OHC trauma with reduced serum prestin levels, and studies suggesting subclinical hearing damage in humans regularly engaging in noisy activities, we investigated the relation between serum prestin levels and environmental noise levels in young adults with normal clinical audiograms. We measured prestin protein levels from circulating blood and collected noise level data multiple times over the course of the experiment using body-worn sound recorders. Results indicate that serum prestin levels have a negative relation with noise exposure: individuals with higher routine noise exposure levels tended to have lower prestin levels. Moreover, when grouping participants based on their risk for a clinically-significant noise-induced hearing loss, we found that prestin levels differed significantly between groups, even though behavioral hearing thresholds were similar. We discuss possible interpretations for our findings including whether lower serum levels may reflect subclinical levels of OHC damage, or possibly an adaptive, protective mechanism in which prestin expression is downregulated in response to loud environments.
“…Previous reports suggested that EHF audiometry is generally better than standard audiometry and OAEs at detecting the early stages, i.e., small levels, of OHC loss 31 , 36 . Moreover, although we previously found a weak correlation between serum prestin levels and TEOAEs 15 , unlike serum prestin, TEOAEs did not correlate with noise exposure levels in the current study. Thus, either noise-related OHC damage is too small to be detected by audiometry and TEOAEs but can be detected by serum prestin levels, or low serum prestin levels in the At-Risk group is being driven by a factor other than OHC loss, as we consider next.…”
Section: Discussioncontrasting
confidence: 99%
“…That is, prestin may be removed from the inner ear as part of the normal proteomic recycling (turnover) processes that maintain cellular homeostasis. Consistent with this proposed homeostatic mechanism, we have previously shown that the healthy ear has stable levels of prestin molecules in circulation 15 . Possible mechanisms for uptake, recycling, and sorting of plasma-membrane proteins, such as prestin in the OHCs.…”
Section: Introductionsupporting
confidence: 66%
“…The results of our previous studies led us to hypothesize that lower levels of serum prestin could follow cochlear injury and be the result of fewer in-tact OHCs undergoing normal prestin production and turnover 15 , 17 , 18 . In our animal model studies, significant noise-induced loss of OHCs was confirmed histologically and manifested as noise induced changes in distortion product OAE levels and auditory brainstem response thresholds 17 , 18 .…”
Section: Discussionmentioning
confidence: 99%
“…We have previously used animal models to demonstrate changes to serum prestin after a traumatic noise event that resulted in hearing loss from OHC death 17 , 18 . A parallel literature is also emerging in humans 15 , 19 , 20 . For example, in our recent work in young adults with clinically normal audiograms (the current clinical gold standard for diagnosing sensorineural hearing loss from noise or other sources), we demonstrated that serum prestin levels have high test–retest reliability, using an experimental approach where serum was obtained at five time points over the span of multiple months 15 .…”
Section: Introductionmentioning
confidence: 96%
“…A parallel literature is also emerging in humans 15 , 19 , 20 . For example, in our recent work in young adults with clinically normal audiograms (the current clinical gold standard for diagnosing sensorineural hearing loss from noise or other sources), we demonstrated that serum prestin levels have high test–retest reliability, using an experimental approach where serum was obtained at five time points over the span of multiple months 15 . We found that while serum prestin levels were stable over this time window on the individual level, there was considerable between-subject variation, despite all participants having clinically normal audiometric function.…”
Serological biomarkers of inner ear proteins are a promising new approach for studying human hearing. Here, we focus on the serological measurement of prestin, a protein integral to a human’s highly sensitive hearing, expressed in cochlear outer hair cells (OHCs). Building from recent nonhuman studies that associated noise-induced OHC trauma with reduced serum prestin levels, and studies suggesting subclinical hearing damage in humans regularly engaging in noisy activities, we investigated the relation between serum prestin levels and environmental noise levels in young adults with normal clinical audiograms. We measured prestin protein levels from circulating blood and collected noise level data multiple times over the course of the experiment using body-worn sound recorders. Results indicate that serum prestin levels have a negative relation with noise exposure: individuals with higher routine noise exposure levels tended to have lower prestin levels. Moreover, when grouping participants based on their risk for a clinically-significant noise-induced hearing loss, we found that prestin levels differed significantly between groups, even though behavioral hearing thresholds were similar. We discuss possible interpretations for our findings including whether lower serum levels may reflect subclinical levels of OHC damage, or possibly an adaptive, protective mechanism in which prestin expression is downregulated in response to loud environments.
Noise‐induced hearing loss (NIHL) often presents with an insidious onset, resulting from the cumulative effect of chronic, high‐level noise exposure regardless of etiology. Stereocilin (STRC) is a protein that supports stereocilia attachment and cochlear hair cell function, 2 common targets of noise trauma. In this study, we explored the relationship between STRC and daily noise exposure in young, healthy adults. We found that higher noise exposure levels were associated with lower serum levels of STRC, as was the case for another inner‐ear protein, prestin. There was a statistically significant positive correlation between serum STRC and prestin levels. These results support a biomarker approach for the diagnosis and monitoring of NIHL. The ability to detect and measure STRC in the blood also has implications for targeted gene therapy. STRC mutations are known to be associated with autosomal recessive deafness, a condition that is now amenable to targeted gene therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.